1. Home
  2. LQDA vs BLDR Comparison

LQDA vs BLDR Comparison

Compare LQDA & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

SELL

Current Price

$34.32

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

SELL

Current Price

$54.74

Market Cap

5.7B

ML Signal

SELL

Company Overview

Basic Information
Metric
LQDA
BLDR
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.7B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
LQDA
BLDR
Price
$34.32
$54.74
Analyst Decision
Buy
Buy
Analyst Count
8
24
Target Price
$54.38
★ $71.36
AVG Volume (30 Days)
★ 4.6M
2.3M
Earning Date
11-02-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.81
N/A
EPS
★ 1.26
N/A
Revenue
$158,320,000.00
★ $15,190,638,000.00
Revenue This Year
$357.27
N/A
Revenue Next Year
$1.34
$2.18
P/E Ratio
$27.38
★ N/A
Revenue Growth
★ 1031.18
N/A
52 Week Low
$21.97
$49.67
52 Week High
$93.61
$131.50

Technical Indicators

Market Signals
Indicator
LQDA
BLDR
Relative Strength Index (RSI) 34.77 42.25
Support Level $32.63 N/A
Resistance Level $42.62 $61.82
Average True Range (ATR) 2.90 1.89
MACD 0.11 0.16
Stochastic Oscillator 23.72 56.78

Price Performance

Historical Comparison
LQDA
BLDR

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

Share on Social Networks: